JOHN WILEY & SONS, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data JOHN WILEY & SONS, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	1,719	1,796	1,800	1,831	1,942	2,083	2,020	1,873	1,678	1,677
Cost of revenue	501	531	555	591	625	701	693	580	431	432
Gross profit	1,258	1,265	1,245	1,241	1,316	1,382	1,327	1,293	1,246	1,245
Selling, general and administrative	943	953	964	997	1,023	1,080	1,037	1,014	947	896
General and administrative	179	184	169	180
Operating expenses	989	995
Operating income	211	231	224	-54.3	186	219	55.9	52.3	221	277
Interest expense	16.9	13.3	16.1	25	18.4	19.8	37.7	49	52.5	43.8
Other non-operating income				13.4	16.8	9.69	3.88	-3.96	5.5	-6.53
Pre-tax income	191	214	213	-63.1	176	210	33.1	-187	143	215
Income tax	77.5	21.7	44.7	11.2	27.7	61.4	15.9	13.3	58.7	-6.53
Net income	114	192	168	-74.3	148	148	17.2	-200	84.2	222
EBITDA	368	385	385	121	386	434	269	229	369	420
EPS, basic	1.98	3.37	2.94	-1.32	2.65	2.66	0.31	-3.65	1.56	4.22
EPS, diluted	1.95	3.32	2.91	-1.32	2.63	2.62	0.31	-3.65	1.53	4.16
Shares, basic (weighted)	57.3	57	57.2	56.2	55.9	55.8	55.6	54.9	54.1	52.5
Shares, diluted (weighted)	58.2	57.9	57.8	56.2	56.5	56.6	56.4	54.9	54.8	53.2

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	58.5	170	92.9	202	93.8	100	107	83.2	85.9	75.6
Receivables	189	212	307	309	312	332	310	224	228	244
Inventory	47.9	39.5	35.6	43.6	42.5	36.6	30.7	26.2	22.9	19.3
Other current assets	64.7	58.3	67.4	59.5	78.4	81.9	93.7	86	103	80.6
Total current assets	360	480	503	615	526	551	541	454	440	420
Property, plant and equipment	243	290	289	298	282	272	247	192	162	136
Lease right-of-use assets			0	143	121	112	91.2	69.1	66.1	57.1
Goodwill	982	1,020	1,096	1,117	1,304	1,302	1,204	1,091	1,122	1,132
Intangible assets	828	848	866	807	1,015	931	855	616	595	579
Other non-current assets	84.5	85.8	97.3	98.6	197	194	170	284	307	267
Total assets	2,606	2,839	2,949	3,169	3,446	3,362	3,109	2,725	2,691	2,592
Accounts payable	76.3	90.1	91	93.7	95.8	77.4	84.3	55.7	60.9	67.2
Accrued liabilities	98.2	116	97.2	108	145	117	80.5	97	93.1	71.1
Deferred revenue	436	486	519	520	545	538	505	484	463	451
Short-term debt			0	9.38	12.5	18.8	5	7.5	10	12.5
Total current liabilities	788	874	882	927	989	969	896	873	821	779
Long-term debt	365	360	479	766	809	768	743	767	789	671
Lease liabilities			0	160	146	133	116	94.4	81.5	69.5
Other non-current liabilities	75.1	80.8	96.2	75.4	92.1	90.5	79.1	71.8	70.4	65.7
Total liabilities	1,603	1,649	1,767	2,235	2,355	2,219	2,064	1,986	1,939	1,744
Total debt	365	360	479	775	822	787	748	775	799	683
Paid-in capital	388	407	422	432	444	459	470	474	482	487
Retained earnings	1,715	1,834	1,931	1,780	1,850	1,921	1,861	1,583	1,591	1,738
Treasury stock	-676	-694	-746	-786	-796	-813	-840	-873	-925	-1,018
Other comprehensive income	-507	-440	-509	-575	-491	-508	-529	-528	-479	-442
Shareholders' equity	1,003	1,191	1,181	934	1,091	1,142	1,045	740	752	848
Total equity	1,003	1,191	1,181	934	1,091	1,142	1,045	740	752	848
Total liabilities and equity	2,606	2,839	2,949	3,169	3,446	3,362	3,109	2,725	2,691	2,592

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	114	192	168	-74.3	148	148	17.2	-200	84.2	222
Depreciation and amortization	157	154	161	175	200	215	213	177	147	143
Stock-based compensation	17.6	11.2	18.3	20	22	25.7	26.5	25	22.2	20.6
Deferred income tax	-28.8	-23.1	-12.7	-27.6	-10.3	3.55	-37.5	-37.9	0.94	-74.7
Change in receivables				2.75	2.19	20.4	-21.8	85.9	-4.21	-15.8
Change in inventory	8	13.5	3.82	-2.71	7.84	2.31	-0.52	5.44	-1.42	6.72
Cash from operations	315	382	251	288	360	339	277	208	203	261
Capital expenditures	-105	-114	-77.2	-88.6	-77.4	-88.8	-81.2	-76.1	-61.5	-51.2
Acquisitions	-126	0	-190	-230	-300	-75.7	-7.29	-3.12	-3.6	-0.24
Cash from investing	-243	-177	-302	-347	-433	-194	-98.4	-107	-94	28.1
Debt issued	683	459	596	934	593	651	1,005	1,185	1,200	965
Debt repaid	-923	-468	-476	-631	-563	-662	-1,044	-1,157	-1,186	-1,086
Stock issued	15.5	29.2	3.75
Share buybacks	-50.3	-39.7	-60	-46.6	-15.8	-30	-35	-45.1	-60.4	-100
Dividends paid	-71.5	-73.5	-75.8	-76.7	-76.9	-77.2	-77.3	-77	-76.1	-74.4
Cash from financing	-346	-96.8	-17.6	173	-47.1	-132	-169	-107	-125	-298
Exchange rate effect	-31	3.66	-8.44	-4.94	11.6	-7.07	-3.57	-1.49	3.15	-0.58
Net change in cash	-305	112	-76.7	109	-109	6.37	6.54	-7.72	-13.6	-10.3
Free cash flow	210	268	174	200	283	250	196	132	141	209
Interest paid	15.7	12.2	14.9	23.6	17.2	17.8	36.1	47.1	51.3	43.1
Income taxes paid	33.7	48.7	48.3	41.5	41.1	48.9	50.9	50.8	53.9	58.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $47.77 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	74.6%	Gross profit / revenue.
Operating margin	14.9%	Operating income / revenue.
EBITDA margin	23.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.1%	Pre-tax income / revenue.
Net margin	11.9%	Net income / revenue.
FCF margin	14.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.4%	Cash from operations / revenue.
Effective tax rate	-7.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	24.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.3%	Net income / average total assets.
Return on invested capital (ROIC)	9.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	53.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.0%	Capital expenditures / revenue.
D&A / revenue	8.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-0.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-6.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-2.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-0.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-2.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	25.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	70.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	8.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	14.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	16.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	1.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	163.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	134.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	8.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	171.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	137.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	9.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	28.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-2.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-6.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	48.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	2.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-5.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-6.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-4.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-3.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-5.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-5.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.64x	Current assets / current liabilities.
Quick ratio	0.46x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.15x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.62x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	41.2%	Total debt / total assets.
Liabilities / assets	74.6%	Total liabilities / total assets.
Net debt	$1.18B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.01x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.32x	Operating income / interest expense.
Working capital	-$250.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	71.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.45B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.53x	Revenue / average total assets.
Fixed asset turnover	12.7x	Revenue / average property, plant and equipment.
Inventory turnover	22.9x	Cost of revenue / average inventory.
Days inventory	16 days	365 x average inventory / cost of revenue.
Receivables turnover	7.91x	Revenue / average receivables.
Days sales outstanding	46 days	365 x average receivables / revenue.
Days payables	39 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	23 days	Days inventory + days sales outstanding - days payables.
FCF conversion	121.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	17.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.91	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$32.83	Revenue / diluted weighted shares.
FCF per share	$4.73	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.72	Cash from operations / diluted weighted shares.
Book value per share	$15.70	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$28.51	Tangible book value / shares outstanding.
Cash per share	$2.10	(Cash + short-term investments) / shares outstanding.
Payout ratio	37.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	30.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	42.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.42B	Share price x shares outstanding.
Enterprise value	$3.61B	Market cap + total debt - cash - short-term investments.
P/E	12.2x	Market cap / net income. Only when net income is positive.
P/S	1.46x	Market cap / revenue.
P/B	3.04x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	10.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.35x	Market cap / cash from operations, when positive.
EV/Sales	2.17x	Enterprise value / revenue.
EV/EBIT	14.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.18x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.9%	Free cash flow / market cap.
Earnings yield	8.2%	Net income / market cap (the inverse of P/E).
Dividend yield	3.0%	Dividends paid over the period / market cap.
Shareholder yield	7.2%	(Dividends paid + share buybacks) / market cap.
PEG	0.09x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was JOHN WILEY & SONS, INC.'s revenue in fiscal 2026?

JOHN WILEY & SONS, INC. reported revenue of $1.68B for fiscal 2026, 0.1% lower than the year before.

Was JOHN WILEY & SONS, INC. profitable in fiscal 2026?

Yes. Net income was $221.6M, a net margin of 13.2%.

How much free cash flow did JOHN WILEY & SONS, INC. generate in fiscal 2026?

Cash from operations of $260.5M minus capital expenditures of $51.2M left free cash flow of $209.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to JOHN WILEY & SONS, INC.